DIAZ REINALDO M 4
4 · Inozyme Pharma, Inc. · Filed Jun 14, 2022
Insider Transaction Report
Form 4
DIAZ REINALDO M
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-10+9,367→ 9,367 totalExercise: $4.38Exp: 2032-06-09→ Common Stock (9,367 underlying)
Footnotes (1)
- [F1]The option was granted on June 10, 2022. The shares underlying the option are scheduled to vest as to 100% of the shares on June 10, 2023, or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date.